Dupixent (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
Approval in moderate-to-severe patients was based on pivotal trial results showing over…
UNITED BREWERIES, WELLA, JIO BP, LIBERTY MUTUAL INSURANCE TO LEAD AT 2025 INDIA EDITION OF BREAK THE CEILING TOUCH THE SKY
India's most successful organizations and inspirational leaders to exchange best practices on…
